Quarterly report pursuant to Section 13 or 15(d)

SELECTED FINANCIAL STATEMENT CAPTIONS - LIABILITIES (Details)

v3.21.2
SELECTED FINANCIAL STATEMENT CAPTIONS - LIABILITIES (Details) - USD ($)
$ in Thousands
Mar. 31, 2021
Dec. 31, 2020
Accounts payable:    
Clinical and regulatory expenses $ 531 $ 262
Professional fees 418 252
Selling expenses 339 395
Manufacturing costs 11 596
Other vendors 100 518
Total accounts payable 1,399 2,023
Accrued interest payable, related parties 54 41
Accrued interest payable 491 627
Accrued expenses:    
Payroll expenses 1,083 1,053
Government rebates and other rebates 2,193 2,659
Due to EJ Holdings 371 545
Other accrued expenses 400 512
Total accrued expenses 4,047 4,769
Total accounts payable and accrued expenses $ 5,991 $ 7,460